Dipen M. Maru is a Professor at The University of Texas MD Anderson Cancer Center, where he specializes in gastrointestinal pathology and oncology. His research focuses on colorectal cancer evolution and micrometastasis, esophageal cancer biology, and the tumor immune microenvironment. His recent work includes the ASCEND-CRC program for cancer evolution profiling, spatial multi-omics dissection of colorectal micrometastasis, and clinical trials of perioperative chemo-immunotherapy for localized esophageal adenocarcinoma. He has also contributed to studies on SMARCA4-deficient esophageal carcinoma and the ADAPT learning cancer treatment system. His publications span Cancer Cell, Nature Communications, and the Journal of Clinical Oncology.